Skip to main content
. 2016 Feb 22;71(5):454–461. doi: 10.1136/thoraxjnl-2015-208123

Figure 4.

Figure 4

One-month washout design for a second-generation modulator studied in a population with access to a robust approved modulator. Subjects receiving the approved modulator are randomised 1:1 to receive the candidate modulator or placebo. Subjects can be optionally rolled over to active modulator for additional information.